NL8120217A - - Google Patents

Download PDF

Info

Publication number
NL8120217A
NL8120217A NL8120217A NL8120217A NL8120217A NL 8120217 A NL8120217 A NL 8120217A NL 8120217 A NL8120217 A NL 8120217A NL 8120217 A NL8120217 A NL 8120217A NL 8120217 A NL8120217 A NL 8120217A
Authority
NL
Netherlands
Prior art keywords
phthalimidoethanesulfone
compounds
taurine
chloride
butylamide
Prior art date
Application number
NL8120217A
Other languages
English (en)
Dutch (nl)
Original Assignee
Medica Pharmaceutical Company, Ltd. Te Helsinki.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medica Pharmaceutical Company, Ltd. Te Helsinki. filed Critical Medica Pharmaceutical Company, Ltd. Te Helsinki.
Publication of NL8120217A publication Critical patent/NL8120217A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
NL8120217A 1980-06-06 1981-05-22 NL8120217A (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8004261A SE434638B (sv) 1980-06-06 1980-06-06 Nya terapeutiska verdefulla taurinderivat och deras framstellning
SE8004261 1980-06-06
PCT/FI1981/000037 WO1981003492A1 (en) 1980-06-06 1981-05-22 Chemical compounds,their production,and their use in drugs
FI8100037 1981-05-22

Publications (1)

Publication Number Publication Date
NL8120217A true NL8120217A (da) 1982-08-02

Family

ID=20341162

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8120217A NL8120217A (da) 1980-06-06 1981-05-22

Country Status (26)

Country Link
US (1) US4556673A (da)
JP (1) JPS57500877A (da)
AT (1) AT376206B (da)
BE (1) BE889100A (da)
CA (1) CA1165322A (da)
CH (1) CH647505A5 (da)
CS (2) CS235088B2 (da)
DD (1) DD159427A5 (da)
DE (1) DE3152071C2 (da)
DK (1) DK155521B (da)
ES (1) ES502761A0 (da)
FI (1) FI67214C (da)
FR (1) FR2486077B1 (da)
GB (1) GB2093457B (da)
HU (1) HU184871B (da)
IE (1) IE51264B1 (da)
IL (1) IL62824A (da)
IT (1) IT8122151A0 (da)
NL (1) NL8120217A (da)
NO (1) NO155840C (da)
PL (2) PL128574B1 (da)
PT (1) PT73061B (da)
SE (1) SE434638B (da)
SU (1) SU1097198A3 (da)
WO (1) WO1981003492A1 (da)
ZA (1) ZA813387B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE458606B (sv) * 1987-04-10 1989-04-17 Huhtamaeki Oy 2-ftalimidoetansulfon-n-arylamider och foerfarande foer framstaellning av dessa
US5801195A (en) * 1994-12-30 1998-09-01 Celgene Corporation Immunotherapeutic aryl amides
AR016384A1 (es) * 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
US6020358A (en) * 1998-10-30 2000-02-01 Celgene Corporation Substituted phenethylsulfones and method of reducing TNFα levels
AU2006200033B8 (en) * 1998-10-30 2008-09-11 Celgene Corporation Substituted phenethylsulfones and methods of reducing TNF-alpha levels
US6667316B1 (en) 1999-11-12 2003-12-23 Celgene Corporation Pharmaceutically active isoindoline derivatives
US6326388B1 (en) 1999-12-21 2001-12-04 Celgene Corporation Substituted 1,3,4-oxadiazoles and a method of reducing TNF-alpha level
US6699899B1 (en) * 1999-12-21 2004-03-02 Celgene Corporation Substituted acylhydroxamic acids and method of reducing TNFα levels
US8030343B2 (en) * 2000-06-08 2011-10-04 Celgene Corporation Pharmaceutically active isoindoline derivatives
US7491634B2 (en) * 2006-04-28 2009-02-17 Asm International N.V. Methods for forming roughened surfaces and applications thereof
WO2003000654A1 (en) * 2001-06-26 2003-01-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem Valproyltaurinamide derivatives as anticonvulsant and cns active agents
US7244759B2 (en) 2004-07-28 2007-07-17 Celgene Corporation Isoindoline compounds and methods of making and using the same
CN114539106B (zh) * 2022-03-15 2023-05-02 梯尔希（南京）药物研发有限公司 一种稳定同位素标记的牛磺酰胺盐酸盐的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2184279A (en) * 1937-11-27 1939-12-26 Squibb & Sons Inc Amino-aliphatic sulphonamides and process for preparing them
AT219039B (de) * 1959-05-27 1962-01-10 Geigy Ag J R Verfahren zur Herstellung von neuen Isoindolinderivaten
GB1254414A (en) * 1969-05-08 1971-11-24 Shun-Ichi Naito Novel aminoethanesulfonylamino derivatives and their production
US4093723A (en) * 1976-05-19 1978-06-06 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl) cephalosporins
ZA76757B (en) * 1975-03-18 1977-01-26 Smithkline Corp New cephalosporin compounds
US4048311A (en) * 1976-01-08 1977-09-13 Smithkline Corporation 7-Acyl-3-(sulfonic acid and sulfamoyl substituted tetrazolyl thiomethyl)cephalosporins
US4066762A (en) * 1976-07-12 1978-01-03 Smithkline Corporation Derivatives of 7-(2-substituted-2-hydroxyiminoacetamido)-3-(1-substituted tetrazol-5-ylthiomethyl-3-cephem-4-carboxylic acid

Also Published As

Publication number Publication date
DE3152071T1 (de) 1983-10-20
SE434638B (sv) 1984-08-06
ES8203342A1 (es) 1982-04-01
CS235088B2 (en) 1985-04-16
ZA813387B (en) 1982-06-30
WO1981003492A1 (en) 1981-12-10
FR2486077B1 (da) 1988-08-12
DD159427A5 (de) 1983-03-09
FI67214B (fi) 1984-10-31
IE51264B1 (en) 1986-11-26
NO155840C (no) 1987-06-10
PL128321B1 (en) 1984-01-31
SU1097198A3 (ru) 1984-06-07
FI821650L (fi) 1982-05-11
PT73061B (en) 1982-07-01
NO155840B (no) 1987-03-02
IL62824A (en) 1984-07-31
GB2093457B (en) 1984-03-21
CS235091B2 (en) 1985-04-16
US4556673A (en) 1985-12-03
HU184871B (en) 1984-10-29
SE8004261L (sv) 1981-12-07
IT8122151A0 (it) 1981-06-05
FR2486077A1 (da) 1982-01-08
DK155521B (da) 1989-04-17
FI67214C (fi) 1985-02-11
DK30082A (da) 1982-01-25
CH647505A5 (de) 1985-01-31
PT73061A (en) 1981-06-01
IL62824A0 (en) 1981-07-31
CA1165322A (en) 1984-04-10
DE3152071C2 (de) 1989-06-15
BE889100A (fr) 1981-12-04
ES502761A0 (es) 1982-04-01
ATA907681A (de) 1984-03-15
IE811037L (en) 1981-12-06
GB2093457A (en) 1982-09-02
PL128574B1 (en) 1984-02-29
JPS57500877A (da) 1982-05-20
PL235510A1 (da) 1982-11-22
PL231531A1 (da) 1982-08-30
FI821650A0 (fi) 1982-05-11
AT376206B (de) 1984-10-25
NO820213L (no) 1982-01-25

Similar Documents

Publication Publication Date Title
NL8120217A (da)
EP0004011A1 (de) Phenoxyalkylcarbonsäure-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US20210122740A1 (en) Solid forms of 2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazine-6-carbonitrile
EP0000174B1 (de) Aminobenzoesäurederivate, Verfahren zu ihrer Herstellung und Arzneimittel enthaltend solche Aminobenzoesäurederivate
DE2701854A1 (de) Hypolipidaemische p-benzylaminobenzoesaeuren und sie enthaltende mittel
DE60013818T2 (de) Quaternäre ammoniumverbindungen, verfahren zu deren herstellung und deren pharmazeutische verwendung
DE2458908C2 (de) Alkanolaminderivate und sie enthaltende pharmazeutische Zusammensetzungen
EP0011747B1 (de) Aminopropanolderivate des 6-Hydroxy-2,3,4,5-tetrahydro-1H-1-benzazepin-2-ons, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
DE2303427C3 (de) Dibenzo-(a,d)-cycloheptadiene und -triene, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2851379A1 (de) Tetrahydrophthalamidderivate
CH512436A (de) Verfahren zur Herstellung basisch substituierter Amide von N-substituierten Anthranilsäuren und ihrer Salze
DD297404A5 (de) Verfahren zur herstellung eines salzes der verbindung 4-[3-[ethyl-(3-(propylsulfinyl)-propyl]-amino)-2-hydroxy-propoxy]-benzonitril
DD295158A5 (de) Verfahren zur herstellung von stereoisomeren der verbindung 4-[3-[ethyl-[3-(propylsulfinyl)-propyl]-amino]-2-hydroxypropoxy]-benzonitril
DE1768974A1 (de) Neue Diarylacetamide und Herstellungsverfahren
DE1957769B2 (de) 4,6-Diamino-1 ^-dihydro-2^-dimethyl-133-triazin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
EP0020941A1 (de) Substituierte 3-(1-Pyrrolidinyl)-5-sulfamoyl-benzoesäure-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Zubereitungen, die sie enthalten und Verfahren zu deren Herstellung
EP1474414B1 (de) Dihydro-thia-phenanthren-carbonyl-guanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum
DE2415691A1 (de) Substituierte benzamide, verfahren zu deren herstellung und deren verwendung
DE2439283A1 (de) Neue pyrimidinderivate und verfahren zu deren herstellung
DE1900948C (de) Cis- und trans-2-Methyl-5-(3, 4, S-trimethoxybenzamidoJ-decahydroisochinolin
SE441450B (sv) Forfarande for framstellning av trankiliserande komplex
AT277249B (de) Verfahren zur Herstellung von neuen Chinolinderivaten
CH610320A5 (en) Process for the preparation of 1-oxo-1H-naphtho[2,1-b]pyran derivatives
DE1793190A1 (de) Verfahren zur Herstellung von 1-Amino-Adamantanen
DE3044333A1 (de) Aminobenzamide, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel